BROYDRICK & ASSOCIATES

Lobbying for TONIX PHARMACEUTICALS · Pharmaceutical development and manufacturing.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $20,000.00 income · posted Apr 19, 2026

Lobbying activity 1

Pharmacy

Funding new drug for PTSD and COVID 19, BARDA appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem